OpenAlex
PricingAboutJobs
Log inGet started
Work

Fc fusion as a platform technology: potential for modulating immunogenicity

HTML

Year: 2014
Type: review
Source: Trends in biotechnology
DOI: 10.1016/j.tibtech.2014.11.001
Authors: Ditza Levin, Basil Golding, Scott E. Strome, Zuben E. Sauna
Institutions: Center for Biologics Evaluation and Research, United States Food and Drug Administration, University of Maryland, Baltimore
Language: English

Topic: Monoclonal and Polyclonal Antibodies Research
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Keywords: Fc fusion protein, immunogenicity, therapeutic proteins, immunomodulation, Fc effector functions, platform technology
SDG: Good health and well-being

Open Access status: closed

Funder: Mayo Clinic
OpenAlex ID: W2051056284
FWCI: 1.171
Cites: 89
Cited by: 204
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms